Format

Send to

Choose Destination
See comment in PubMed Commons below
Rev Urol. 2007;9 Suppl 1:S20-8.

Clinical experience with gene therapy for the treatment of prostate cancer.

Author information

1
Department of Urology, The Barbara and Maurice A. Deane Prostate Health and Research Center, Mount Sinai School of Medicine New York, NY.

Abstract

Localized prostate cancer can be treated effectively with radical prostatectomy or radiation therapy. The treatment options for metastatic prostate cancer are limited to hormonal therapy; hormone-refractory cancer is treated with taxane-based chemotherapy, which provides only a modest survival benefit. New treatments are needed. The gene for the initiation of prostate cancer has not been identified; however, gene therapy can involve tumor injection of a gene to kill cells, systemic gene delivery to target and kill metastases, or local gene expression intended to generate a systemic response. This review will provide an overview of the various strategies of cancer gene therapy, focusing on those that have gone to clinical trial, detailing clinical experience in prostate cancer patients.

PMID:
17387369
PMCID:
PMC1831538
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center